高级搜索
王茹月, 叶雨. 芒柄花黄素应用于抗癌药物开发的研究进展[J]. 肿瘤防治研究, 2019, 46(2): 183-187. DOI: 10.3971/j.issn.1000-8578.2019.18.0643
引用本文: 王茹月, 叶雨. 芒柄花黄素应用于抗癌药物开发的研究进展[J]. 肿瘤防治研究, 2019, 46(2): 183-187. DOI: 10.3971/j.issn.1000-8578.2019.18.0643
WANG Ruyue, YE Yu. Research Progress of Formononetin for Anticancer Drug Development[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 183-187. DOI: 10.3971/j.issn.1000-8578.2019.18.0643
Citation: WANG Ruyue, YE Yu. Research Progress of Formononetin for Anticancer Drug Development[J]. Cancer Research on Prevention and Treatment, 2019, 46(2): 183-187. DOI: 10.3971/j.issn.1000-8578.2019.18.0643

芒柄花黄素应用于抗癌药物开发的研究进展

Research Progress of Formononetin for Anticancer Drug Development

  • 摘要: 芒柄花黄素(Formononetin, FN)及其衍生物已被证明具有多种生物学功能,包括抗氧化、抗病毒和保护作用等,近年来它的抗癌活性得到国内外学者越来越多的关注。本文总结了芒柄花黄素在抗癌药物开发方面的研究进展,并探讨了当前存在的一些问题。

     

    Abstract: Formononetin (FN) and its derivatives have multiple biological functions, such as antioxidant, antiviral and protective effects. In recent years, its anticancer activity has captivated a growing number of attention from researchers all over the world. This review summarized the research progress of formononetin for anticancer drug development, and some existing questions are analyzed.

     

/

返回文章
返回